Author: João Pedro Fonseca; Alain R. Bonny; G. Renuka Kumar; Andrew H. Ng; Jason Town; Qiu Chang Wu; Elham Aslankoohi; Susan Y. Chen; Patrick Harrigan; Lindsey C. Osimiri; Amy L. Kistler; Hana El-Samad
Title: A Toolkit for Rapid Modular Construction of Biological Circuits in Mammalian Cells Document date: 2018_12_26
ID: 1kugu5zk_45
Snippet: To further characterize the ZEBOV-4cis stable RNP cell line system, we also tested their susceptibility to previously identified EBOV small molecule inhibitors: Gedunin, an inhibitor of heat shock protein 90, and 6-Azauridine, a nucleoside analog 31, 32 . ZEBOV-4cis stable cells were transfected with the ZEBOV nLuc minigenome reporter and treated with DMSO (1%, control), Gedunin (5 µM), or 6-Azauridine (5 µM) for 2 days. Luciferase assays revea.....
Document: To further characterize the ZEBOV-4cis stable RNP cell line system, we also tested their susceptibility to previously identified EBOV small molecule inhibitors: Gedunin, an inhibitor of heat shock protein 90, and 6-Azauridine, a nucleoside analog 31, 32 . ZEBOV-4cis stable cells were transfected with the ZEBOV nLuc minigenome reporter and treated with DMSO (1%, control), Gedunin (5 µM), or 6-Azauridine (5 µM) for 2 days. Luciferase assays revealed that both compounds inhibited minigenome activity by >50%, with minimal impact on cell viability (Fig. 7g ). These data indicate that the ZEBOV-4cis stable cell lines generated here are similarly susceptible to known inhibitors identified in transient RNP minigenome systems or recombinant virus systems 31, 32 . Therefore, our approach implemented through the MTK introduces a robust workflow for generating BSL2 systems for filoviruses and other viral agents as they emerge, providing a critical opportunity to implement rapid chemical compound susceptibility screens using these reagents.
Search related documents:
Co phrase search for related documents- cell line and generate cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- cell line and heat shock: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cell line and heat shock protein: 1, 2, 3, 4, 5, 6, 7, 8
- cell line and luciferase assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- cell line and minigenome activity: 1
- cell line and minigenome reporter: 1
- cell line and minigenome system: 1, 2
- cell line and minimal impact: 1, 2
- cell line and nucleoside analog: 1, 2, 3
- cell line and RNP minigenome system: 1
- cell line and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- cell line and small molecule inhibitor: 1, 2, 3
- cell line and stable cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- cell line and stable generate cell line: 1
- cell line and susceptibility test: 1, 2, 3, 4
- cell line and viral agent: 1, 2, 3, 4
- cell line and virus system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- cell line system and generate cell line: 1, 2
- cell line system and minigenome reporter: 1
Co phrase search for related documents, hyperlinks ordered by date